Entest BioMedical Signs LOI with Quantum Advisors to Coordinate Development of COPD Stem Cell Therapy
SAN DIEGO—-Entest BioMedical Inc. announced today that it has signed a Letter of Intent with Quantum Advisors, a San Diego based biotechnology consulting firm, to assist Entest with the development of its Stem Cell Therapeutic Treatment for Chronic Obstructive Pulmonary Disease .
[Read the full article here]Related News:
Bio-Matrix Scientific's Research Subsidiary, Entest BioMedical, Inc., Files Stem Cell Therapy Patent Application For Treatment Of COPD
Entest BioMedical Files 3rd Patent Application for COPD Stem Cell …
Bio-Matrix Scientific Group’s Majority Owned Subsidiary Entest BioMedical Initiates Studies To Support Stem Cell / Laser Regenerative Therapy For COPD